In this podcast episode, Dr Jonathan Meyer answers additional questions from learners at our Psychopharmacology Update conference. Questions explore other disease states where psychosis can occur, practical considerations around special populations, tolerability, drug combinations, and the potential future of muscarinic-based therapies. For additional activities in this program including a ClinicalThought commentary, a CME/CE/CPE certified on-demand webcast and a downloadable slideset, go to: https://bit.ly/4qjcYcj

Faculty:

Jonathan M. Meyer, MD, DLFAPA
Voluntary Clinical Professor of Psychiatry
University of California, San Diego
Senior Academic Adviser
California Department of State Hospitals
San Diego, California

Get access to all of our new podcasts by subscribing to the CCO Neuroscience Podcast on Apple Podcasts, YouTube Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of “Cognitive Conversations,” expert faculty discuss breaking data presentations from the 2026 Clinical Trials on Alzheimer’s Disease conference held in San Diego, California, from December 1-4, 2025, and their implications for clinical practice.

Topics covered include:

• Evoke and evoke+ phase III trials of semaglutide
• Subcutaneous lecanemab as initiation and maintenance treatment
• Blood-based biomarker assays
• Trontinemab and other brain shuttles
• Tau targeting therapies in development
• Preventive impact of BCG and herpes zoster vaccination

This podcast episode is part of the CME/CE-accredited program, “Early Clues, Lasting Impact: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages,” supported by an educational grant from Novo Nordisk.

Faculty:

Anton P. Porsteinsson, MD
William B. and Sheila Konar Professor of Psychiatry, Neurology, and Neuroscience, and Medicine
Director, Alzheimer's Disease Care, Research and Education Program (AD-CARE)
University of Rochester School of Medicine and Dentistry
Rochester, New York

Vijay K. Ramanan, MD, PhD
Consultant and Associate Professor
Director, Alzheimer’s Disease Treatment Clinic
Department of Neurology
Mayo Clinic
Rochester, Minnesota

Link to obtain CME/CE credit:
https://bit.ly/4999otE

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast episode, epilepsy specialists Danielle Becker, MD, MS, FAES, and Sarah Weatherspoon, MD, discuss the personalization of the most recently available epilepsy rescue treatments for younger kids and their implementation by the patient care team.

Faculty:

Danielle Becker, MD, MS, FAES
Division Director of Epilepsy
Associate Professor of Neurology
The Ohio State University Wexner Medical Center
Columbus, Ohio

Sarah Weatherspoon, MD
Associate Chief of Child Neurology
Tuberous Sclerosis Center of Excellence, Neurology Co-Director
Le Bonheur Children's Hospital
University of Tennessee Health Science Center
Memphis, Tennessee

Resources mentioned in this episode:

• Epilepsy Foundation Seizure Action Plan Toolkit
• CDC Managing Epilepsy Well (MEW) Network

Link to Brain Health Hub with additional educational activities:
https://bit.ly/3Y12Isx

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.